Overview

BAY86-5046 (Betaseron), Non Interventional Studies

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate adherence to therapy among patients treated with Betaferon who are using the BETACONNECT autoinjector.
Details
Lead Sponsor:
Bayer
Treatments:
Interferon beta-1b
Interferon-beta
Interferons